![]() ![]() Scores from zero to two are low risk, three to five are intermediate risk, and scores six to seven are high risk.Įach of the points on the scale can be understood as follows: The TIMI score can range between one and seven. The higher the TIMI score, the more likely you are to be at risk for heart problems and death. Specific markers in your cardiac healthĮach one of these categories represents one point on the TIMI scale.Dramatic changes on your electrocardiogram scans.Severe unstable angina in the past twenty-four hours.Having at least three risk factors for coronary artery disease, such as diabetes, hypertension, smoking, or a family history of heart disease.Some of the criteria used to score the TIMI are: Blood testing and an electrocardiogram can determine if you have had an NSTEMI event. It can be caused by diabetes, coronary artery disease, high cholesterol, hypertension, and smoking. Symptoms of NSTEMI are chest pain, dizziness, nausea, shortness of breath, and sweating. This is a type of heart attack in which one of the coronary arteries is blocked, and the blood flow of oxygen-rich blood is reduced. Non-ST-Elevation myocardial infarction (NSTEMI).It can easily lead to heart attacks, arrhythmia (irregular heartbeat), or cardiac arrest (when the heart stops beating and needs to be restarted). Unstable angina should be treated with caution. The fatty buildup can burst and cause blood clotting that blocks blood flow to the heart. It is usually caused by fatty buildup in the arteries providing blood flow to your heart (your coronary arteries). Also called acute coronary syndrome, the most common symptom of this condition is chest pain that occurs unexpectedly while you are at rest. The main risk factors that prompt calculating a TIMI score are: Only people who are considered at high or medium risk are given a TIMI classification. TIMI risk scores are used to guide treatment and find the best options for your heart condition. The score measures risks for people who have certain types of chest pain or heart attacks. Finally, we outline an up-to-date treatment approach that starts with identification of an individualized goal for glycemic control then selection, initiation, and further intensification of a personalized therapeutic plan for T2D.A TIMI risk score is based on a number of factors and is used to estimate how likely it is that someone might have serious or life-threatening heart consequences. We also review targets of novel therapeutic T2D agent development. Each class of agents is presented by mechanism of action, details of administration, side effect profile, cost, and use in certain populations including heart failure, non-alcoholic fatty liver disease, obesity, chronic kidney disease, and older individuals. This review aims to provide an updated summary of the pharmacotherapeutic approach to T2D. Type 2 diabetes (T2D) is a widely prevalent disease with substantial economic and social impact for which multiple conventional and novel pharmacotherapies are currently available however, the landscape of T2D treatment is constantly changing as new therapies emerge and the understanding of currently available agents deepens. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |